As of 2025-05-23, the EV/EBITDA ratio of Youngy Health Co Ltd (300247.SZ) is 34.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300247.SZ's latest enterprise value is 2,996.06 mil CNY. 300247.SZ's TTM EBITDA according to its financial statements is 87.07 mil CNY. Dividing these 2 quantities gives us the above 300247.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 22.6x - 26.7x | 25.3x |
| Forward P/E multiples | 10.3x - 13.0x | 12.2x |
| Fair Price | 1.55 - 3.10 | 2.37 |
| Upside | -60.7% - -21.3% | -39.8% |
| Date | EV/EBITDA |
| 2024-12-20 | 35.89 |
| 2024-12-19 | 35.61 |
| 2024-12-18 | 36.17 |
| 2024-12-17 | 35.80 |
| 2024-12-16 | 39.03 |
| 2024-12-13 | 39.68 |
| 2024-12-12 | 40.04 |
| 2024-12-11 | 38.47 |
| 2024-12-10 | 37.64 |
| 2024-12-09 | 38.75 |
| 2024-12-06 | 38.66 |
| 2024-12-05 | 37.74 |
| 2024-12-04 | 36.81 |
| 2024-12-03 | 37.64 |
| 2024-12-02 | 38.01 |
| 2024-11-29 | 37.09 |
| 2024-11-28 | 35.52 |
| 2024-11-27 | 34.60 |
| 2024-11-26 | 34.50 |
| 2024-11-25 | 33.95 |
| 2024-11-22 | 33.30 |
| 2024-11-21 | 34.97 |
| 2024-11-20 | 35.52 |
| 2024-11-19 | 34.23 |
| 2024-11-18 | 33.21 |
| 2024-11-15 | 35.06 |
| 2024-11-14 | 36.81 |
| 2024-11-13 | 38.57 |
| 2024-11-12 | 38.66 |
| 2024-11-11 | 39.21 |
| 2024-11-08 | 40.23 |
| 2024-11-07 | 39.31 |
| 2024-11-06 | 38.11 |
| 2024-11-05 | 37.27 |
| 2024-11-04 | 36.44 |
| 2024-11-01 | 35.70 |
| 2024-10-31 | 40.41 |
| 2024-10-30 | 36.81 |
| 2024-10-29 | 39.68 |
| 2024-10-28 | 35.61 |
| 2024-10-25 | 31.18 |
| 2024-10-24 | 29.06 |
| 2024-10-23 | 28.59 |
| 2024-10-22 | 28.96 |
| 2024-10-21 | 28.22 |
| 2024-10-18 | 28.41 |
| 2024-10-17 | 26.93 |
| 2024-10-16 | 26.56 |
| 2024-10-15 | 26.28 |
| 2024-10-14 | 26.01 |